TREATMENT OF OBSTRUCTIVE SLEEP APNEA IN CHILDREN: A SCOPING REVIEW

Tuấn Quyết Phạm, Quang Trung Nguyễn

Main Article Content

Abstract

Objective: This review was conducted to describe and synthesize treatment options for the management of obstructive sleep apnea (OSA) in children. Method: Searching strategy was combining terms about (1) Obstructive Sleep Apnea, (2) Pediatric và (3) Treatment in PubMed/MEDLINE, Science Direct, and Google Scholar. Original research papers in English and Vietnamese on OSA treatment methods were selected. Data from selected studies was extracted and classified into themes and topics. The PRISMA principles were used to perform a scoping evaluation of several medical databases. Results: This research includes fifteen studies in all, it was found that a total of 07 studies applied the Adenotonsillectomy, 04 studies used Montelukast in treatment, 03 studies used intranasal corticosteroids, 02 The study focused on methods of semi-rapid maxillary expansion and Rapid maxillary expansion, and 01 study related to adenopharyngoplasty. These treatments not only significantly reduce AHI, an important indicator of OSA severity, but also improve oxygen saturation and sleep efficiency. Conclusions: Adenotonsillectomy is one of the first-line surgical treatments for OSA in children with high treatment effectiveness. In addition, Montelukast and intranasal corticosteroids have also been suggested as a potential nonsurgical treatment option for children with OSA.

Article Details

References

1. Marcus CL, Brooks LJ, Draper KA, et al. Diagnosis and management of childhood obstructive sleep apnea syndrome. Pediatrics. 2012; 130(3), 576–584.
2. Gozal D. Pediatric sleep apnea: an update. European Respiratory Review. 2018; 27(147), 180097.
3. Farber JM. Clinical practice guideline: diagnosis and management of childhood obstructive sleep apnea syndrome. Pediatrics. 2002; 110(6), 1255–1257; author reply 1255-1257.
4. Chervin RD, Ellenberg SS, Hou X, et al. Prognosis for Spontaneous Resolution of OSA in Children. Chest. 2015; 148(5), 1204–1213.
5. Zhang J, Chen J, Yin Y, et al. Therapeutic effects of different drugs on obstructive sleep apnea/hypopnea syndrome in children. World J Pediatr. 2017; 13(6), 537–543.
6. Kheirandish-Gozal L, Bhattacharjee R, Bandla HPR, et al. Antiinflammatory therapy outcomes for mild OSA in children. Chest. 2014; 146(1), 88–95.
7. Bisgaard H, Skoner D, Boza ML, et al. Safety and tolerability of montelukast in placebo-controlled pediatric studies and their open-label extensions. Pediatr Pulmonol. 2009; 44(6), 568–579.
8. Villa MP, Rizzoli A, Miano S, et al. Efficacy of rapid maxillary expansion in children with obstructive sleep apnea syndrome: 36 months of follow-up. Sleep Breath. 2011; 15(2), 179–184.